CRO News
Arlington Capital Explores Sale of CRO Everest Clinical Research
Arlington Capital Partners is preparing a potential sale of Everest Clinical Research, a Toronto-based contract research organization (CRO), according to people familiar with the process. The private equity firm has recently interviewed sell-side advisors as it moves toward formally marketing the
24 March 2026